Mayne Pharma's sales are now 83% branded drugs, up from 32% two years ago, focusing on dermatology and women's health.
Why it mattersBranded drugs command higher prices and better margins than generics. This shift strengthens Mayne's profitability and competitive position.
Free. Be genuinely informed in 5 minutes a day. No signup, no noise.
Get the free app, read the whole feed
InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.